Barbalata, C.-I.; Porfire, A.S.; Casian, T.; Muntean, D.; Rus, I.; Tertis, M.; Cristea, C.; Pop, A.; Cherfan, J.; Loghin, F.;
et al. The Use of the QbD Approach to Optimize the Co-Loading of Simvastatin and Doxorubicin in Liposomes for a Synergistic Anticancer Effect. Pharmaceuticals 2022, 15, 1211.
https://doi.org/10.3390/ph15101211
AMA Style
Barbalata C-I, Porfire AS, Casian T, Muntean D, Rus I, Tertis M, Cristea C, Pop A, Cherfan J, Loghin F,
et al. The Use of the QbD Approach to Optimize the Co-Loading of Simvastatin and Doxorubicin in Liposomes for a Synergistic Anticancer Effect. Pharmaceuticals. 2022; 15(10):1211.
https://doi.org/10.3390/ph15101211
Chicago/Turabian Style
Barbalata, Cristina-Ioana, Alina Silvia Porfire, Tibor Casian, Dana Muntean, Iulia Rus, Mihaela Tertis, Cecilia Cristea, Anca Pop, Julien Cherfan, Felicia Loghin,
and et al. 2022. "The Use of the QbD Approach to Optimize the Co-Loading of Simvastatin and Doxorubicin in Liposomes for a Synergistic Anticancer Effect" Pharmaceuticals 15, no. 10: 1211.
https://doi.org/10.3390/ph15101211
APA Style
Barbalata, C. -I., Porfire, A. S., Casian, T., Muntean, D., Rus, I., Tertis, M., Cristea, C., Pop, A., Cherfan, J., Loghin, F., & Tomuta, I.
(2022). The Use of the QbD Approach to Optimize the Co-Loading of Simvastatin and Doxorubicin in Liposomes for a Synergistic Anticancer Effect. Pharmaceuticals, 15(10), 1211.
https://doi.org/10.3390/ph15101211
